Lichen planus in hepatitis C virus infection: An early marker that may save lives

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 16, Issue 1, 2007, Pages 3-6

  Maticic M ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Hepatitis C; Lichen planus

Indexed keywords

HEPATITIS C ANTIBODY;

CHRONIC LIVER DISEASE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE MARKER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LICHEN PLANUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PORPHYRIA CUTANEA TARDA; PREVALENCE; REVIEW; SJOEGREN SYNDROME; UNITED STATES; VIRUS REPLICATION;

HEPATITIS C, CHRONIC; HUMANS; LICHEN PLANUS; UNITED STATES;

EID: 34147194988     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) and HCV-related chronic diseases. MMWR Morb Mortal Wkly Rep 1998;47:1-33.
2. World Health Organization. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec, 1999;74(49):425.
3. Alter HJ, Conry-Cantelena C, Malpolder J, et al. Hepatitis C in asymptomatic blood donors. Hepatology 1997;26(3) Suppl 1:S29-33.
4. Thomas DL, Astemborsky J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral and environmental factors. JAMA 2000;284:450-6.
5. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequences. Hepatology 2006;44:15-20.
6. Zignego AL, Ferry C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of hepatitis C virus infection: A general overview and guidelines for a clinical approach. Dig Liver Dis 2007;39:2-17.
7. Cacoub P Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment hepatitis C virus. Arthritis Rheum 1999;42:2204-12.
8. DeRossi SS, Ciarrocca KN. Lichen planus, lichenoid drug reactions, and lichenoid mucositis. Dent Clin North Am 2005;49:77-89.
9. Nagao Y, Sata M. Hepatitis C and lichen planus. J Gastroenterol Hepatol 2004;19:1101-13.
10. Rebora A, Patri P, Rampini E. Erosive lichen planus and cirrhotic hepatitis. Ital Gen Rev Dermatol 1978;15:23-31.
11. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
12. Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998;9:86-122.
13. Sigurgeirsson B, Lindelof B. Lichen planus and malignancy: an epidemiologic study of 2071 patients and review of the literature. Arch Dermatol 1991;127:1684-8.
14. Chainani-Wu N, Lozada-Nur F, Terrault N. Hepatitis C virus and lichen planus: A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:171-83.
15. Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: Report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:40-51.
16. Lodi G, Giuliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 2004;151:1172-81.
17. Ibrahim HA, Baddour MM, Morsi MG, Abdelkader AA. Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis? East Mediterr Health J 1999;5:71-8.
18. Daramola OO, George AO, Ogunbiyi AO. Hepatitis C virus and lichen planus in Nigerians: Any relationship? Int J Dermatol 2002;41:217-9.
19. Carrozzo M. Oral health in patients with hepatitis C virus infection: an underestimated problem? Oral Dis 2001;7(5):267-70.
20. Dervis E, Serez K. The prevalence of dermatologic manifestations related to chronic hepatitis C virus infection in a study from a single center in Turkey. Acta Dermatoveneral Alp Pannonica Adriat 2005;14:93-8.
21. Carrozzo M, Brancatella F, Danatto E, et al. Hepatitis C virus-associated oral lichen planus: Is the geographical heterogeneity related to HLA-DR6? J Oral Pathol Med 2005;34:204-8.
22. Lodi G. Hepatitis C virus and lichen planus. Evid Based Dent 2006;7(1):18.
23. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
24. Armstrong GL, Alter MJ, McQuillian GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31:777-82.
25. Everson GT. Management of cirrhosis due to chronic hepatitis C. J Hepatol 2005;42 Suppl 1:S65-74.
26. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management and treatment of hepatitis C. Hepatology 2004;39:1147-71.
27. Anon. National Institutes of Health Consensus Development Conference statement. Management of hepatitis C: 2000. Hepatology 2002;36 Suppl 5:S3-20.
28. Hadziyannis SJ, Sette H, Morgan TR, et al. Peginterferon alfa-2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140:346-55.
29. Poynard T, Beydossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-32.
30. Poynard T, McHutchinson J, Davies GL, et al. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chrome hepatitis C. Hepatology 2000;32:1131-7.